Alexion Pharmaceuticals Inc. (ALXN) Share Price ($):80.41 Price Change: 3.72 (4.85%)

Volume 2,365,202 Avg Volume 1,168,700
Day's Low $76.81 Day's High $83.10
52-wk Low $43.78 52-wk High $83.10
Previous Close $76.69 Open Price $79.00
Dividend $0.00 Yield 0.00%
Market Cap 14,177,400 P/E (Forward) 50.45
Chart for ALXN
Exchange: NASDAQ Industry: Drug Manufacturers/Other Last Trade: 4:00 PM ET 2/9/2012
Last 10 Quotes: What's This?
    Find a Broker »

    Earnings & Forecast

    Compare More
    Most Recent Quarter ($)Same Quarter Last Year ($)% Change
    EPS, Pro Forma 0.34 0.15 126.67
    EPS, GAAP 0.34 0.15 126.67
    Consensus Estimate 0.23 0.19 21.05
    Trailing 12 MonthsYear-Earlier Period% Change
    EPS, Pro Forma 1.02 0.73 39.73
    EPS, GAAP 0.80 1.70 -52.94
    Consensus Estimate 0.87 NA NA

    Key Statistics

    Compare More
    ALXNIndustry Average
    P/E (TTM) 95.86 29.50
    P/E (Forward) 50.45 -4.30
    PEG Ratio 1.65 -0.21
    Price/Sales 20.70 4.56
    Beta 0.54 0.36

    Stories & Blogs: Around the Web

    2/7/2012  There's no need to try and guess which company will perform best. (The Motley Fool)
    1/17/2012  S&P, Dow rattle cage on five-month highs (MarketWatch.com)
    1/12/2012  Demand will only rise with a growing and aging population. (The Motley Fool)
    1/5/2012  Good signs, but let's not call it a trend yet. (The Motley Fool)
    1/4/2012  Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX) (24/7 Wall St)
    12/30/2011  Deals of the Day: Don't Let Your Congressman Manage Your Portfolio (WSJ.com)
    12/29/2011  Alexion makes a big purchase. (The Motley Fool)
    12/29/2011  Stocks to watch Thursday: Alexion, Mosaic, Exar (MarketWatch.com)
    • Print Snapshot
    • Dynamic Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools
    From the Magazine
    Read More Read More Read More Read More

    Also